跳至主要内容
临床试验/IRCT201410073449N17
IRCT201410073449N17已完成3 期

Comparing efficacy of Omega-3 and placebo in reducing beck depression score in HIV/AIDS patients

Vice Chancellor for Research, Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 65 years(—)
性别
All

入选标准

  • HIV positive patients with age between 18-65 years old, received antiretroviral therapy for at-least one years, CD4 count=350 and Beck Depression Score (BDS)=16.
  • Exclusion criteria: HIV positive patients suffering from other psychological disorders, major depression with recent suicidal attempt, history of drugs or alcohol abuse, other concomitant severe medical diseases such as diabetes mellitus, intake of omega-3 during last 3 months, sensitivity to omega-3, coagulation disorders or intake of anticoagulants and receiving any drugs that affect patients’ mood including anti-depressants.

排除标准

  • 未提供

研究者

发起方
Vice Chancellor for Research, Tehran University of Medical Sciences

相似试验